Pierre Champelovier

A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivoglioblastoma models

Ahcène Boumendjel, Anne McLeer‐Florin, Pierre Champelovier et al. · BMC Cancer · 2009 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17

EXPRESSION OF E-, P-, N-CADHERINS AND CATENINS IN HUMAN BLADDER CARCINOMA CELL LINES

Geraldine Levacher, Pierre Champelovier, Véronique Martel et al. · The Journal of Urology · 2000 · 47 citations

Medicine, Oncology, Urology +11

Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis

Pierre Champelovier, Nathalie Boucard, Geraldine Levacher et al. · Urological Research · 2002 · 38 citations

Medicine, Oncology, Urology +17

Cellular and molecular mechanisms activating the cell death processes by chalcones: Critical structural effects

Pierre Champelovier, Xavier Chauchet, Florence Hazane‐Puch et al. · Toxicology in Vitro · 2013 · 31 citations

Life Sciences, Cell Biology, Molecular Biology +13

2-Arylidenedihydroindole-3-ones: Design, synthesis, and biological activity on bladder carcinoma cell lines

Bastien Gerby, Ahcène Boumendjel, Madeleine Blanc et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 29 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11